Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 7:11 PM
Ignite Modification Date: 2025-12-24 @ 7:11 PM
NCT ID: NCT02067403
Eligibility Criteria: Inclusion Criteria: Patients who are ventilated using a partial ventilator support mode (i.e. pressure support) and meet one of the following criteria: * Known chronic pulmonary obstructive disease * Suspected Intrinsic PEEP on the expiratory airway pressure and flow tracings * Resistive pressure (i.e. eak pressure-Plateau pressure) higher than 20 centimeters of water (cmH2O) at a flow of 60 L/min or higher than 15 at a flow of 45 L/min in volume controlled ventilation (preferably after a tracheal aspiration maneuver) * Known chronic restrictive pulmonary disease with respiratory failure * Restrictive pulmonary disease characterized by a measured compliance of less than 30 ml/cmH2O * Obesity with BMI ≥ 30 kg/m2 * Existence of frequent asynchronies noticed on the ventilator waveforms * Expected duration of ventilation of more than 24 hours Exclusion Criteria: * Contraindication to Naso/orogastric tube (NGT/OGT) placement (known esophageal problem such as hiatal hernia or esophageal varicosities, active upper gastro-intestinal bleeding, any other contraindication to the insertion of a NGT/OGT) * Poor short term prognosis (defined by the clinician in charge as a high risk of death during the next 7 days) or ongoing palliative treatment. * Patients with "Do not resuscitate" order already established and in palliative care * Patients younger than 18 years old
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT02067403
Study Brief:
Protocol Section: NCT02067403